Abstract. The active form of vitamin D is synthesized by 25-hydroxyvitamin D 1␣-hydroxylase (1␣-hydroxylase), which is expressed predominantly in renal proximal tubular cells. To clarify the mechanism of cell-specific gene expression of this enzyme, the 5'-flanking region of the mouse 1␣-hydroxylase gene was investigated. Investigation began with mRNA expression of 1␣-hydroxylase in cultured cells, including LLC-PK1, NIH/3T3, HepG2, MDCK, and OK cells. Expression of 1␣-hydroxylase mRNA was restricted in LLC-PK1 cells. Several lengths of the 5'-flanking region of 1␣-hydroxylase gene were linked to a pGL3-basic luciferase vector and introduced into these cells. Only LLC-PK1 cells had a substantial luciferase activity. Deletion analyses revealed that luciferase activity was detected in constructs extending from the transcription initiation site to Ϫ1652 to Ϫ105 bp, whereas further deletion to Ϫ80 bp resulted in a marked decrease in activity. The region from Ϫ105 to Ϫ80 bp contained two ternary complex factor-1 (TCF-1) sites, and mutations in the proximal TCF-1 site decreased the activity. Electrophoretic mobility shift assay demonstrated binding of LLC-PK1 nuclear proteins to this region. Tests of enhancer function in LLC-PK1 cells indicated that the 26-bp fragment behaved as a classical enhancer, i.e., independently of position and orientation. Moreover, a decoy oligonucleotide corresponding to this region substantially inhibited the promoter activity of 1␣-hydroxylase gene. This study suggests that the Ϫ105 to Ϫ80 bp element of mouse 1␣-hydroxylase gene contains an enhancer to be necessary for renal proximal tubular cell-specific expression. We and other investigators have recently cloned rat (6,7), mouse (8), human (9,10), and porcine (11) cDNAs of 1␣-hydroxylase. The complete sequences of mouse and human 1␣-hydroxylase genes have also been reported (9,(12)(13)(14). It has been demonstrated that mutations in the 1␣-hydroxylase gene cause vitamin D dependency rickets type I, which is characterized by early onset of hypocalcemia, secondary hyperparathyroidism, and severe rachitic lesions (10,15,16). Northern blot analyses have revealed 1␣-hydroxylase mRNA expression to be localized mainly in the kidney (9,15). This result is consistent with the previous studies that the kidney is the principal site of 1␣,25-(OH) 2 D synthesis, although several extrarenal cells, including keratinocytes (17), placental decidual cells (18), and pulmonary macrophages (19) also have 1␣-hydroxylase activity. Extrarenal 1␣-hydroxylase does not contribute to circulating 1␣,25-(OH) 2 D concentrations and acts in an intracrine manner.The mechanism that the 1␣-hydroxylase gene is predominantly expressed in renal proximal tubular cells clearly warrants study. Little is known about proximal tubular cell-specific gene expression, although several investigations have focused on the mechanism responsible for the kidney-specificity or other nephron segments-specificity (20 -24). We hypothesized that some cell-specific transcriptional regulators bo...